How to buy Chembio Diagnostics stock

Chembio Diagnostics, Inc is a diagnostics & research business based in the US. Chembio Diagnostics shares (CEMI) are listed on the NASDAQ and all prices are listed in US Dollars. Chembio Diagnostics employs 355 staff and has a trailing 12-month revenue of around 0.00.

Chembio Diagnostics share price

Use our graph to track the performance of CEMI stocks over time.

Chembio Diagnostics shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$3.01 - $14.83
50-day moving average	$4.04
200-day moving average	$5.20
Wall St. target price	$9.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.73

Buy Chembio Diagnostics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Chembio Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Chembio Diagnostics, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Chembio Diagnostics financials

Revenue TTM	$32.5 million
Gross profit TTM	$-912,784
Return on assets TTM	-22.75%
Return on equity TTM	-98.52%
Profit margin	-78.6%
Book value	$1.38
Market capitalisation	$82.5 million

TTM: trailing 12 months

Shorting Chembio Diagnostics shares

There are currently 2.4 million Chembio Diagnostics shares held short by investors – that's known as Chembio Diagnostics's "short interest". This figure is 23.2% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting Chembio Diagnostics shares can be evaluated.

Chembio Diagnostics's "short interest ratio" (SIR)

Chembio Diagnostics's "short interest ratio" (SIR) is the quantity of Chembio Diagnostics shares currently shorted divided by the average quantity of Chembio Diagnostics shares traded daily (recently around 13.5 million). Chembio Diagnostics's SIR currently stands at 0.18. In other words for every 100,000 Chembio Diagnostics shares traded daily on the market, roughly 180 shares are currently held short.

However Chembio Diagnostics's short interest can also be evaluated against the total number of Chembio Diagnostics shares, or, against the total number of tradable Chembio Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chembio Diagnostics's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Chembio Diagnostics shares in existence, roughly 120 shares are currently held short) or 0.1229% of the tradable shares (for every 100,000 tradable Chembio Diagnostics shares, roughly 123 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chembio Diagnostics.

Find out more about how you can short Chembio Diagnostics stock.

Chembio Diagnostics share dividends

We're not expecting Chembio Diagnostics to pay a dividend over the next 12 months.

Have Chembio Diagnostics's shares ever split?

Chembio Diagnostics's shares were split on a 1:8 basis on 29 May 2012. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Chembio Diagnostics shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Chembio Diagnostics shares which in turn could have impacted Chembio Diagnostics's share price.

Chembio Diagnostics share price volatility

Over the last 12 months, Chembio Diagnostics's shares have ranged in value from as little as $3.01 up to $14.83. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chembio Diagnostics's is 1.8312. This would suggest that Chembio Diagnostics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Chembio Diagnostics overview

Chembio Diagnostics, Inc. , together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, Hepatitis C, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, Rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.

Frequently asked questions

• What percentage of Chembio Diagnostics is owned by insiders or institutions?

  Currently 8.85% of Chembio Diagnostics shares are held by insiders and 43.409% by institutions.

• How many people work for Chembio Diagnostics?

  Latest data suggests 355 work at Chembio Diagnostics.

• When does the fiscal year end for Chembio Diagnostics?

  Chembio Diagnostics's fiscal year ends in December.

• Where is Chembio Diagnostics based?

  Chembio Diagnostics's address is: 555 Wireless Boulevard, Hauppauge, NY, United States, 11788

• What is Chembio Diagnostics's ISIN number?

  Chembio Diagnostics's international securities identification number is: US1635722093

• What is Chembio Diagnostics's CUSIP number?

  Chembio Diagnostics's Committee on Uniform Securities Identification Procedures number is: 163572100